AstraZeneca Urges Fed. Circ. To Find Asthma Inhaler IP Valid
Pharmaceutical giant AstraZeneca PLC urged a Federal Circuit panel Monday to revive its pediatric asthma medication patent, saying the lower court disregarded evidence when it declared the patent's claims obvious in...To view the full article, register now.
Already a subscriber? Click here to view full article